9-(Tert-butyl) 2-ethyl 1-oxo-6-oxa-9-azaspiro[4.5]Decane-2,9-dicarboxylate, 98%, 1g

4-Fluoro-3-methylphenol, 98.0%, 10g

6-Chloro-3-hydroxypyridazine-4-carboxylic acid, 95.0%, 10g

Potassium 1,3-benzoxazole-2-carboxylate, 95.0%, 5g

2-(2-(4-Chlorophenyl)acetyl)benzoic acid, 95.0%, 100g

DL-Cystine, min. 98.5%, 1 g, glass packaging

2,5-Dimethylhexanedioic acid, 98%, 100mg

4-(1-((tert-Butoxycarbonyl)amino)cyclopropyl)benzoic acid, 95%, 1g

2-Amino-4,4,4-trifluorobutyric Acid Hydrochloride>98.0%(N)1g

L-Histidine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-1-[(4-methylphenyl)diphenylmethyl]-, 96%, 5g

4-Pentyl-N-((3-(4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)methyl)benzenesulfonamide, 98%, 100mg

METHYL 4-METHYLCINNAMATE, 95%, 100g

Glycidyl Methacrylate (stabilized with MEHQ)>95.0%(GC)25g